- Home
- FLWS vs NBP Comparison
FLWS vs NBP Comparison
Compare FLWS & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLWS | NBP |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 242.3M | 205.9M |
| IPO Year | 1999 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FLWS | NBP |
|---|---|---|
| Price | $2.68 | $1.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 383.7K | ★ 594.7K |
| Earning Date | 05-07-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,151,921,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.41 | $1.32 |
| 52 Week High | $7.10 | $5.19 |
Technical Indicators
Market Signals| Indicator | FLWS | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 32.32 | 27.50 |
| Support Level | $2.41 | N/A |
| Resistance Level | $4.32 | $1.67 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 26.12 | 15.19 |
Price Performance
Historical ComparisonAbout FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.